Understanding the PHQ-9: Depression Screening Explained

What Is the PHQ-9?

The Patient Health Questionnaire-9 (PHQ-9) is a nine-item self-report depression screening tool developed from the broader PHQ developed by Drs. Robert Spitzer, Janet Williams, and Kurt Kroenke. It was designed specifically for use in primary care settings where depression frequently goes undetected.

The PHQ-9 has become the gold standard for depression screening in the United States and is used globally. It's fast (takes 2–3 minutes to complete), validated across multiple populations, and sensitive to changes over time — making it useful both for initial screening and for tracking treatment response.

The tool is grounded in DSM criteria for major depressive disorder. Each of the nine items corresponds directly to one of the nine diagnostic symptoms of depression defined in the DSM.

The Nine Questions

The PHQ-9 asks how often in the past two weeks you have been bothered by each of the following. Responses range from 0 (Not at all) to 3 (Nearly every day).

A tenth item — not part of the score — asks how difficult these problems have made it to do your work, take care of things at home, or get along with other people. This functional impairment question helps contextualize the score and is important clinical information.

PHQ-9 Scoring

The total PHQ-9 score is the sum of all nine item scores, ranging from 0 to 27. Each item is scored 0–3, where 0 = "Not at all" and 3 = "Nearly every day."

What a PHQ-9 Score Tells You (and What It Doesn't)

The PHQ-9 is a screening tool, not a diagnosis. A high score indicates that depressive symptoms are present at a clinically meaningful level and that further evaluation is warranted — but it doesn't tell you:

• Whether depression is the primary cause of the symptoms (medical conditions like hypothyroidism, anemia, and chronic pain can produce similar symptom profiles)
• Whether the symptoms represent major depressive disorder, bipolar disorder, seasonal affective disorder, or another condition with a different treatment approach
• What medication, therapy type, or combination would be most appropriate for your specific presentation

This is why a screening score is the beginning of a clinical conversation, not the end of one. A primary care physician, psychiatrist, or psychologist can contextualize your score within your full health picture and help identify the right next steps.

Using the PHQ-9 to Track Progress

One of the PHQ-9's most valuable features is its sensitivity to change over time. When administered repeatedly — typically every 2–4 weeks during active treatment — the PHQ-9 provides an objective measure of whether symptoms are improving, stable, or worsening.

Clinicians and researchers generally use the following benchmarks:

• Response: A reduction of 50% or more in PHQ-9 score from baseline indicates a clinically meaningful response to treatment
• Remission: A score below 5 indicates remission from major depression
• Worsening: An increase of 5 or more points may indicate inadequate response or a need to reassess the treatment plan

This makes the PHQ-9 particularly useful in collaborative care models where primary care providers and mental health specialists share data, and in settings where patients track their own symptoms between appointments.

Limitations of the PHQ-9

The PHQ-9 is one of the most validated screening tools in medicine, but it has known limitations:

It can over-identify in certain populations

In people with serious chronic illness, many PHQ-9 symptoms — fatigue, sleep disturbance, appetite changes, concentration difficulties — may reflect the physical illness rather than depression. This is particularly relevant in palliative care settings. Modified approaches, such as the PHQ-9 with a "cause attribution" option, have been developed for medically ill patients.

Cultural and linguistic variation

The PHQ-9 has been translated into over 80 languages and validated across many populations. However, cultural differences in how depression is expressed and discussed can affect responses. Some culturally specific presentations of distress — somatic symptoms, social withdrawal, irritability — may not be fully captured by the standard items.

It doesn't distinguish between disorders

A high PHQ-9 score cannot distinguish between major depressive disorder, bipolar depression, dysthymia, or adjustment disorder. The treatment implications of these diagnoses differ significantly. The PHQ-9 screens for symptom burden; differential diagnosis requires a clinical interview.

Taking the PHQ-9 on GentleHorizon

GentleHorizon's depression screening tool walks you through a validated PHQ-9 assessment, calculates your score in real time, explains what your result means in plain language, and helps you understand what next steps make sense for your situation. No login required, results stay on your device.

After Your Screening: What to Do with Your Results

If your score falls in the mild to moderate range or above, the most important next step is sharing that result with a healthcare provider. Bring your score to your primary care physician — most are now trained in depression management and can provide initial treatment or a referral.

If cost or access to care is a barrier, community mental health centers, federally qualified health centers, and telehealth platforms have expanded substantially and many offer sliding-scale fees.

If your score reflects severe symptoms or if Item 9 is elevated, please don't wait for an appointment. Contact the 988 Suicide and Crisis Lifeline (call or text 988) or go to your nearest emergency department.